KAYLA CHAPMAN: Open Payments
NPI 1932658184 · ISSAQUAH, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,705 in 199 payments from 16 companies in 2025. Trend: 2023 $3,727 · 2024 $3,297 · 2025 $3,705
Food & beverage: $3,499Education: $206
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $842 |
| Janssen Biotech, Inc. | 34 | $767 |
| UCB, Inc. | 23 | $411 |
| Arcutis Biotherapeutics, Inc. | 18 | $303 |
| Regeneron Healthcare Solutions, Inc. | 7 | $259 |
| Novartis Pharmaceuticals Corporation | 16 | $227 |
| Galderma Laboratories, L.P. | 9 | $214 |
| Organon LLC | 15 | $184 |
| Incyte Corporation | 4 | $95 |
| Lilly USA, LLC | 4 | $81 |
Products named: TREMFYA, SKYRIZI, Bimzelx, Zoryve, DUPIXENT, RINVOQ, NEMLUVIO, COSENTYX.
Industry payments across WA — which companies pay providers there.
